Quantbot Technologies LP Biomarin Pharmaceutical Inc Transaction History

Quantbot Technologies LP

  • $2.36 Billion
  • Q3 2024

A detailed history of Quantbot Technologies LP transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Quantbot Technologies LP holds 2,427 shares of BMRN stock, worth $159,356. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,427
Holding current value
$159,356
% of portfolio
0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$69.02 - $93.84 $167,511 - $227,749
2,427 New
2,427 $170,000
Q2 2023

Aug 08, 2023
BUY
$86.68 - $100.3 $267,061 - $309,024
3,081 New
3,081 $267,000
Q3 2022

Nov 07, 2022
BUY
$82.16 - $96.94 $1.49 Million - $1.76 Million
18,175 Added 528.8%
21,612 $1.83 Million
Q2 2022

Aug 09, 2022
SELL
$71.48 - $86.85 $25,375 - $30,831
-355 Reduced 9.36%
3,437 $284,000
Q1 2022

May 16, 2022
BUY
$74.28 - $92.69 $92,478 - $115,399
1,245 Added 48.88%
3,792 $292,000
Q4 2021

Feb 11, 2022
SELL
$71.72 - $91.47 $138,634 - $176,811
-1,933 Reduced 43.15%
2,547 $225,000
Q3 2021

Nov 09, 2021
BUY
$74.77 - $85.47 $334,969 - $382,905
4,480 New
4,480 $346,000
Q2 2021

Aug 12, 2021
SELL
$75.51 - $84.79 $638,437 - $716,899
-8,455 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$74.73 - $90.69 $631,842 - $766,783
8,455 New
8,455 $638,000
Q4 2020

Feb 12, 2021
SELL
$72.61 - $90.2 $1.23 Million - $1.53 Million
-16,964 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$71.87 - $131.03 $1.22 Million - $2.22 Million
16,964 New
16,964 $1.29 Million
Q4 2019

Feb 10, 2020
SELL
$64.27 - $86.37 $427,202 - $574,101
-6,647 Closed
0 $0
Q3 2019

Nov 12, 2019
BUY
$67.4 - $85.11 $230,845 - $291,501
3,425 Added 106.3%
6,647 $448,000
Q2 2019

Aug 13, 2019
SELL
$80.35 - $93.9 $617,891 - $722,091
-7,690 Reduced 70.47%
3,222 $275,000
Q1 2019

May 13, 2019
BUY
$84.2 - $98.62 $918,790 - $1.08 Million
10,912 New
10,912 $969,000
Q4 2018

Feb 13, 2019
SELL
$80.14 - $106.07 $3.06 Million - $4.05 Million
-38,170 Closed
0 $0
Q3 2018

Nov 13, 2018
BUY
$93.92 - $105.72 $3.58 Million - $4.04 Million
38,170 New
38,170 $3.7 Million
Q4 2017

Feb 12, 2018
SELL
$80.76 - $95.13 $228,793 - $269,503
-2,833 Closed
0 $0
Q3 2017

Nov 07, 2017
BUY
$80.6 - $94.95 $228,339 - $268,993
2,833
2,833 $263,000

Others Institutions Holding BMRN

# of Institutions
637
Shares Held
177M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.2B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email